ERS Monograph: Bronchiectasis

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Manuela Funke-Chambour (Department for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital; Lung Precision Medicine, Department for BioMedical Research, University of Bern, Bern; and Division of Pulmonology, Department of Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland) about her Back to Basics review article on the mechanism and treatment implications of inflammation in pulmonary fibrosis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.00258-2026). Cite this podcast as: ERJ Podcast October 2026: The role of inflammation in the pathogenesis of pulmonary fibrosis. Eur Respir J 2026; 68: 26E6804 [https://doi.org/10.1183/13993003.E6804-2026].

"We [should] not only focus on one treatment option but we should discuss how we can combine different options; this has to be studied in more detail" In this instalment of the ERS Monograph podcast, Guido Marchi (Early Career Member representative for the Monograph) meets with two of the Guest Editors of “Obstructive and Central Sleep Apnoea”: Winfried Randerath and Jean-Louis Pépin. In a discussion that highlights the complexity of the field, they consider: how best to assess severity and determine treatment needs; the shift towards combined therapy and personalised treatment; appropriate use of AI and digital tools; and the priorities of future research.

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Christina Thornton and associate editor Marcus Mall about their Back to Basics review article on bridging the airway microbiome and targeted therapy in bronchiectasis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.00239-2026). Cite this podcast as: ERJ Podcast September 2026: The airway microbiome and targeted therapy in bronchiectasis. Eur Respir J 2026; 68: 26E6803 [https://doi.org/10.1183/13993003.E6803-2026].

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marlies van Dijk (University of Groningen, Groningen, The Netherlands) about her multicentre randomised crossover trial of fentanyl and morphine for persistent dyspnoea in COPD, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01431-2025). Cite this podcast as: ERJ Podcast August 2026: Fentanyl or morphine for persistent dyspnoea in COPD. Eur Respir J 2026; 68: 26E6802 [https://doi.org/10.1183/13993003.E6802-2026].

As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marlies Wijsenbeek about data from the whole follow-up period of the FIBRONEER-ILD trial of nerandomilast in progressive pulmonary fibrosis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025). English and Japanese versions of the patient podcast to accompany the article are available from: https://publications.ersnet.org/content/erj/68/1/2501899#edit-group-supplementary-material Cite this podcast as: ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis. Eur Respir J 2026; 68: 26E6801 [https://doi.org/10.1183/13993003.E6801-2026].

"Making ultrasound as widespread and as used as the stethoscope... that's the big challenge going forwards" The latest ERS Monograph podcast focuses on an area that is evolving into a cornerstone of respiratory practice: thoracic ultrasound. Guido Marchi (Monograph Early Career Member representative) talks to Guest Editors of the Thoracic Ultrasound Monograph, Vineeth George and Christian B. Laursen. Their discussion covers key milestones and advances in the field, effective training, maintaining skills, research priorities and future opportunities. It is a conversation and, indeed, a book that truly reflects a challenging and inspiring research agenda.

As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Melanie Königshoff (Center for Lung Aging and Regeneration, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, and Geriatric Research Education and Clinical Center at the VA Pittsburgh Healthcare System, Pittsburgh, PA, USA) about her Back to Basics review of the hallmarks of the ageing lung, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025). Cite this podcast as: ERJ Podcast June 2026: The ageing lung. Eur Respir J 2026; 67: 26E6706 [https://doi.org/10.1183/13993003.E6706-2026].

As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews John Fahy (Division of Pulmonary and Critical Care Medicine, and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA) about his state-of-the-art review of the pathobiology and treatment of mucus plugs in asthma and COPD , published in this issue of the ERJ (https://doi.org/10.1183/13993003.02358-2025). Cite this podcast as: ERJ Podcast May 2026: Mucus plugs in asthma and COPD. Eur Respir J 2026; 67: 26E6705 [https://doi.org/10.1183/13993003.E6705-2026].

"Patient voice should not be something we add at the end of the process. We should acutally shape the entire process, from the beginning, with the patient." Key leaders of EMBARC (the European Multicentre Audit and Research Collaboration) Amelia Shoemark and Stefano Aliberti join Guido Marchi in a podcast focusing on the latest ERS Monograph: Bronchiectasis. Guido, who is the Early Career Member representative for the Monograph, asks Stefano and Amelia about the foundation of EMBARC and its increasing international reach, better integration of the patient voice, the impact of the 2025 European Respiratory Society (ERS) bronchiectasis guidelines, and the turning point in treatment that dipeptidyl peptidase-1 (DPP-1) offers.

As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Sanja Stanojevic about the joint statement from the Global Initiative for Chronic Obstructive Lung Disease and the Global Lung Function Initiative regarding the use of spirometry to define airflow obstruction and diagnose COPD, published in this issue of the ERJ (https://doi.org/10.1183/13993003.02574-2025). Cite this podcast as: ERJ Podcast April 2026: Use of spirometry to define airflow obstruction and diagnose COPD. Eur Respir J 2026; 67: 26E6704. [https://doi.org/10.1183/13993003.E6704-2026]